Homepage > Company > Media > Pharma News > 2018 > Lupin intros generic Vibra-Tabs

Lupin intros generic Vibra-Tabs

Lupin has introduced its generic Vibra-Tabs (doxycycline hyclate). The company’s generic will be available in 100-mg dosage strength tablets.

Lupin’s generic of Pfizer’s Vibra-Tabs is indicated to treat infections caused by various microorganisms, and as an adjunctive treatment for severe acne.

The product had U.S. sales of roughly $144 million for the 12 months ended November 2017, according to IQVIA data.

January 19, 2018

https://www.drugstorenews.com/

Read also

Ventus and Genentech

Ventus and Genentech partner for small-molecule medicine discovery

Aspire Pharma’s

Acquisition strengthens Aspire Pharma’s strategic portfolio

Alkermes to acquire Avadel for $2.1bn

Alkermes has agreed to acquire Avadel Pharmaceuticals for up to $20 per share in cash, valuing Avadel at $2.1bn.

NanoViricides

NanoViricides reports antiviral activity of NV-387 against measles in preclinical studies